Facebook Linkedin Twitter
Inside Precision Medicine Oncogene Linked to Worsening of Blood Vessel Malformations in Brain

Cervical cancer

Results from a new study show the validity of using CSF as a medium for finding ctDNA to detect brain tumors. [Jonathan Bailey
News & Features

Oncogene Linked to Worsening of Blood Vessel Malformations in Brain

0
Human papilloma virus, illustration
News & Features

Variants in Three Genes Linked with Increased Cervical Cancer Risk

0
Esophageal cancer, illustration
Molecular Dx

Lucid Diagnostics’ Esophageal DNA Test Gets FDA Breakthrough Designation

0
Ovarian Cancer
Molecular Dx

Single-Cell Sequencing Provides Insights into Ovarian Cancer Subtypes

0
Illustration of female reproductive system including uterus and ovaries to represent ovarian cancer
Molecular Dx

Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery

0
Cervical Microbiome May Promote Cancer
Molecular Dx

Cervical Microbiome May Promote Cancer

0
Novacyt said today it is selling its NOVAprep® next-generation
Molecular Dx

Novacyt to Sell NOVAprep Cytology Solution, Clinical Lab Businesses

0
Agilent Technologies’ Dako PD-L1 IHC 22C3 pharmDx assay has become the first FDA-approved companion diagnostic to identify patients with cervical cancer for treatment with Merck & Co.'s cancer immunotherapy Keytruda (pembrolizumab). [Agilent Technologies]
Molecular Dx

Agilent CDx for Keytruda Gets FDA Approval for Cervical Cancer

0
Clinical OMICs Magazine Volume 1, Issue No. 11
News & Features

Clinical OMICs Magazine Volume 1, Issue No. 11

0
A recent report estimates the global demand for PCR technologies in 2013 to be around $10.6 billion. [Caleb Foster - Fotolia.com]
Molecular Dx

Expanding End-Use Segments Drive PCR Growth Worldwide

Syamala Ariyanchira, Ph.D.
0
1...345Page 4 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine